FDA NDC Directory · JSON-LD · Markdown

RISPERDAL M-TAB

NDC 50458-325 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Generic namerisperidone
Labeler / ManufacturerJanssen Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021444
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsRISPERIDONE (2 mg/1)
Marketing started20030402
Package count0

External sources

Source: openFDA. Public-domain (CC0).